Pharmacological therapies for male infertility.

antioxidants testosterone

Journal

Pharmacological reviews
ISSN: 1521-0081
Titre abrégé: Pharmacol Rev
Pays: United States
ID NLM: 0421737

Informations de publication

Date de publication:
21 Oct 2024
Historique:
accepted: 15 10 2024
received: 04 06 2024
revised: 25 09 2024
medline: 22 10 2024
pubmed: 22 10 2024
entrez: 21 10 2024
Statut: aheadofprint

Résumé

Male factor infertility is a multifaceted problem that affects approximately 50% of couples suffering from infertility. Causes of male infertility include endocrine disturbances, gonadotoxins, genetic abnormalities, varicocele, malignancies, infections, congenital or acquired urogenital abnormalities, iatrogenic factors, immunological factors, and idiopathic reasons. There are a variety of treatment options for male infertility, depending on the underlying cause(s). These can include surgical treatments, medical/hormonal therapies, and assisted reproductive techniques (ART), which can be combined with surgical sperm retrieval (SSR) if necessary. In this review article, the pharmacological therapies for male infertility are grouped by their underlying causes. Some of these therapies are targeted and specific, while others are used empirically to treat idiopathic male infertility. This will include treatments to optimize infertility in patients who have hypogonadism, ejaculatory dysfunction, infections, or idiopathic male infertility. Finally, we will provide an overview of the future directions of pharmacological therapies for male infertility.

Identifiants

pubmed: 39433442
pii: pharmrev.124.001085
doi: 10.1124/pharmrev.124.001085
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Society for Pharmacology and Experimental Therapeutics.

Auteurs

Amarnath Rambhatla (A)

Department of Urology,, Henry Ford Health System, United States.

Rupin Shah (R)

Division of Andrology, Department of Urology,, Lilavati Hospital and Research Centre,, Mexico.

Germar M Pinggera (GM)

Innsbruck Medical University, Austria.

Taymour Mostafa (T)

Faculty of Medicine, Cairo University, Egypt.

Widi Atmoko (W)

Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Indonesia.

Ramadan Saleh (R)

Faculty of Medicine, Sohag University,, Egypt.

Eric Chung (E)

Urology, University of Queensland, Australia.

Taha Hamoda (T)

King Abdulaziz University, Saudi Arabia.

Selahittin Cayan (S)

University of Mersin School of Medicine, Turkey.

Hyun Jun Park (H)

Medical Research Institute of Pusan National University Hospital, Korea, Democratic People's Republic of.

Ates Kadioglu (A)

Istanbul University, Turkey.

Logan Hubbard (L)

Thomas Jefferson University, United States.

Ashok Agarwal (A)

Global Andrology Forum, United States agarwaa32099@outlook.com.

Classifications MeSH